Scenarios that move XBI
State Street SPDR S&P Biotech ETF
Scenarios that move XBI: 6 analyses, 5 positive, 1 negative.
- · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▲ · impact +12 · confidence low · horizon immediate
- · Spyre Therapeutics prices $350 million public stock offering — ▲ · impact +30 · confidence low · horizon weeks
- · Kodiak Sciences shares soar 178% on positive wet AMD data — ▲ · impact +22 · confidence low · horizon weeks
- · Ionis reports positive late-stage results for two partnered drugs — ▲ · impact +15 · confidence low · horizon immediate
- · Oruka Therapeutics reports positive week 28 ORKA-001 trial data — ▲ · impact +20 · confidence low · horizon immediate
- · Beta Bionics prices public offering of stock and warrants — ▼ · impact -25 · confidence low · horizon immediate